These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2404751)

  • 1. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.
    Katzenellenbogen BS; Norman MJ
    Endocrinology; 1990 Feb; 126(2):891-8. PubMed ID: 2404751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H; Aronica SM; Katzenellenbogen BS
    Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
    Aronica SM; Katzenellenbogen BS
    Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin inhibits estrogen action in human breast cancer cells.
    Woodward TL; Lu H; Haslam SZ
    Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
    Daws MR; Westley BR; May FE
    Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.
    Erickson GF; Magoffin DA; Cragun JR; Chang RJ
    J Clin Endocrinol Metab; 1990 Apr; 70(4):894-902. PubMed ID: 2108185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors controlling proliferation and progesterone production by bovine granulosa cells in serum-free medium.
    Savion N; Lui GM; Laherty R; Gospodarowicz D
    Endocrinology; 1981 Aug; 109(2):409-20. PubMed ID: 6454570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I (IGF-I) and IGF-II hormonal action in cultured rat granulosa cells: mediation via type I but not type II IGF receptors.
    Adashi EY; Resnick CE; Rosenfeld RG
    Endocrinology; 1990 Jan; 126(1):216-22. PubMed ID: 2152863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM; Gierthy JF; Pentecost BT
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
    Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
    Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.